Novartis AG - Depositary Receipt (Common Stock)
DE ˙ DB ˙ US66987V1098
121,00 € 0,00 (0,00%)
2026-06-04
AKTIENPREIS
SecurityDE:NOTA / Novartis AG - Depositary Receipt (Common Stock)
InstitutionWebster Bank, N. A.
Latest Disclosed Ownership100 shares
Latest Disclosed Value $ 15,275
Webster Bank, N. A. reports 55.56% decrease in ownership of NOTA / Novartis AG - Depositary Receipt (Common Stock)

On April 17, 2026 - Webster Bank, N. A. filed a 13F-HR form disclosing ownership of 100 shares of Novartis AG - Depositary Receipt (Common Stock) (DE:NOTA) valued at $12,850 USD as of March 31, 2026. The entity filed a previous 13F-HR on January 23, 2026 disclosing 225 shares of Novartis AG - Depositary Receipt (Common Stock). This represents a change in shares of -55.56% during the quarter. The current value of the position is $12,100 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-04-17 2026-03-31 13F NOVARTIS SPONSORED ADR 66987V109 100 -125 -55.56 15 -51.61 0.0014
2026-01-23 2025-12-31 13F NOVARTIS SPONSORED ADR 66987V109 225 0 0.00 31 10.71 0.0029
2025-10-23 2025-09-30 13F NOVARTIS SPONSORED ADR 66987V109 225 -150 -40.00 29 -37.78 0.0028
2025-07-08 2025-06-30 13F NOVARTIS SPONSORED ADR 66987V109 375 0 0.00 45 9.76 0.0047
2025-04-04 2025-03-31 13F NOVARTIS SPONSORED ADR 66987V109 375 0 0.00 42 13.89 0.0046
2025-01-22 2024-12-31 13F Novartis SPONSORED ADR 66987V109 375 0 0.00 36 -16.28 0.0039
2024-10-10 2024-09-30 13F Novartis SPONSORED ADR 66987V109 375 0 0.00 43 10.26 0.0046
2024-07-12 2024-06-30 13F Novartis SPONSORED ADR 66987V109 375 0 0.00 40 8.33 0.0044
2024-04-16 2024-03-31 13F Novartis SPONSORED ADR 66987V109 375 0 0.00 36 -2.70 0.0041
2024-01-23 2023-12-31 13F Novartis SPONSORED ADR 66987V109 375 0 0.00 38 -2.63 0.0046
2023-10-10 2023-09-30 13F Novartis SPONSORED ADR 66987V109 375 -650 -63.41 38 -63.11 0.0052
2023-07-13 2023-06-30 13F Novartis SPONSORED ADR 66987V109 1,025 0 0.00 103 9.57 0.0134
2023-04-13 2023-03-31 13F Novartis SPONSORED ADR 66987V109 1,025 0 0.00 94 0.0123
2023-01-18 2022-12-31 13F Novartis SPONSORED ADR 66987V109 1,025 -150 -12.77 0 -100.00 0.0126
2022-10-24 2022-09-30 13F Novartis SPONSORED ADR 66987V109 1,175 0 0.00 89 -10.10 0.0129
2022-07-12 2022-06-30 13F Novartis SPONSORED ADR 66987V109 1,175 -925 -44.05 99 -46.20 0.0135
2022-04-13 2022-03-31 13F Novartis SPONSORED ADR 66987V109 2,100 925 78.72 184 78.64 0.0132
2022-01-12 2021-12-31 13F Novartis SPONSORED ADR 66987V109 1,175 -75 -6.00 103 0.98 0.0107
2021-10-12 2021-09-30 13F Novartis SPONSORED ADR 66987V109 1,250 -400 -24.24 102 -32.45 0.0114
2021-07-20 2021-06-30 13F Novartis SPONSORED ADR 66987V109 1,650 -125 -7.04 151 0.00 0.0165
2021-05-07 2021-03-31 13F Novartis SPONSORED ADR 66987V109 1,775 -174 -8.93 151 -17.93 0.0172
2021-01-07 2020-12-31 13F Novartis SPONSORED ADR 66987V109 1,949 -141 -6.75 184 1.10 0.0216
2020-10-22 2020-09-30 13F Novartis SPONSORED ADR 66987V109 2,090 -110 -5.00 182 -5.21 0.0239
2020-07-09 2020-06-30 13F Novartis SPONSORED ADR 66987V109 2,200 0 0.00 192 6.08 0.0272
2020-04-21 2020-03-31 13F Novartis SPONSORED ADR 66987V109 2,200 -250 -10.20 181 -21.98 0.0301
2020-01-14 2019-12-31 13F Novartis SPONSORED ADR 66987V109 2,450 50 2.08 232 11.00 0.0296
2019-10-01 2019-09-30 13F Novartis SPONSORED ADR 66987V109 2,400 0 0.00 209 -4.57 0.0283
2019-07-11 2019-06-30 13F NOVARTIS SPONSORED ADR 66987V109 2,400 0 0.00 219 -5.19 0.0302
2019-04-10 2019-03-31 13F NOVARTIS SPONSORED ADR 66987V109 2,400 -175 -6.80 231 5.00 0.0330
2019-01-09 2018-12-31 13F NOVARTIS SPONSORED ADR 66987V109 2,575 0 0.00 220 -0.90 0.0355
2018-10-12 2018-09-30 13F NOVARTIS SPONSORED ADR 66987V109 2,575 -465 -15.30 222 -3.06 0.0309
2018-07-12 2018-06-30 13F Novartis SPONSORED ADR 66987V109 3,040 -575 -15.91 229 -21.84 0.0331
2018-04-19 2018-03-31 13F Novartis SPONSORED ADR 66987V109 3,615 -900 -19.93 293 -22.69 0.0423
2018-01-23 2017-12-31 13F Novartis SPONSORED ADR 66987V109 4,515 -325 -6.71 379 -8.89 0.0521
2017-10-12 2017-09-30 13F Novartis SPONSORED ADR 66987V109 4,840 -2,100 -30.26 416 -28.15 0.0605
2017-07-12 2017-06-30 13F Novartis SPONSORED ADR 66987V109 6,940 0 0.00 579 12.21 0.0857
2017-05-01 2017-03-31 13F Novartis SPONSORED ADR 66987V109 6,940 -1,025 -12.87 516 -11.19 0.0778
2017-02-15 2016-12-31 13F Novartis SPONSORED ADR 66987V109 7,965 -360 -4.32 581 -11.57 0.0849
2016-10-14 2016-09-30 13F NOVARTIS AG SPONSORED ADR COMMON STOCK 66987V109 8,325 -55 -0.66 657 -4.92 0.0956
2016-07-11 2016-06-30 13F NOVARTIS AG SPONSORED ADR COMMON STOCK 66987V109 8,380 -1,245 -12.94 691 -0.86 0.1013
2016-04-12 2016-03-31 13F NOVARTIS AG SPONSORED ADR COMMON STOCK 66987V109 9,625 -3,240 -25.18 697 -37.04 0.1088
2016-01-13 2015-12-31 13F NOVARTIS AG SPONSORED ADR COMMON STOCK 66987V109 12,865 -1,029 -7.41 1,107 -13.31 0.1776
2015-11-12 2015-09-30 13F NOVARTIS AG SPONSORED ADR COMMON STOCK 66987V109 13,894 -221 -1.57 1,277 -8.00 0.2353
2015-07-09 2015-06-30 13F NOVARTIS AG SPONSORED ADR COMMON STOCK 66987V109 14,115 -825 -5.52 1,388 -5.83 0.2323
2015-04-30 2015-03-31 13F NOVARTIS AG SPONSORED ADR COMMON STOCK 66987V109 14,940 -350 -2.29 1,474 4.02 0.2437
2015-01-15 2014-12-31 13F NOVARTIS AG SPONSORED ADR COMMON STOCK 66987V109 15,290 -3,750 -19.70 1,417 -20.93 0.2377
2014-10-15 2014-09-30 13F NOVARTIS AG SPONSORED ADR COMMON STOCK 66987V109 19,040 -3,575 -15.81 1,792 -12.46 0.3169
2014-07-09 2014-06-30 13F NOVARTIS AG SPONSORED ADR COMMON STOCK 66987V109 22,615 -22,175 -49.51 2,047 -46.24 0.3532
2014-04-11 2014-03-31 13F NOVARTIS AG SPONSORED ADR COMMON STOCK 66987V109 44,790 -1,860 -3.99 3,808 1.55 0.5261
2014-01-28 2013-12-31 13F NOVARTIS AG SPONSORED ADR COMMON STOCK 66987V109 46,650 -900 -1.89 3,750 2.80 0.5249
2013-11-05 2013-09-30 13F NOVARTIS AG SPONSORED ADR COMMON STOCK 66987V109 47,550 -59,144 -55.43 3,648 -51.64 0.5616
2013-08-06 2013-06-30 13F NOVARTIS AG SPONSORED ADR COMMON STOCK 66987V109 106,694 106,694 7,544 0.9515
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.